StockMacro
Menu

Teleflex

$161.58 +23% in 6 monthsMarket cap $6.4B

TFX on XNYS, Health Care, Teleflex Incorporated, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue fell 38% while shares rose 54% over 12 months and short interest hit 5.2× a year earlier.

  • BadOne restructuring and five director or officer changes in 12 months

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
15,500
Website
teleflex.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 7 Jan 2027 (an estimate: a year ago it reported on 8 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $567.8M, net income $927.4M.
Quarter to 31 Dec 2021: revenue $761.9M, net income $128.1MQuarter to 31 Dec 2021: revenue $761.9M, net income $128.1MQuarter to 27 Mar 2022: revenue $641.7M, net income $77.1MQuarter to 27 Mar 2022: revenue $641.7M, net income $77.1MQuarter to 26 Jun 2022: revenue $704.5M, net income $105.5MQuarter to 26 Jun 2022: revenue $704.5M, net income $105.5MQuarter to 25 Sep 2022: revenue $686.8M, net income $101.9MQuarter to 25 Sep 2022: revenue $686.8M, net income $101.9MQuarter to 31 Dec 2022: revenue $758.0M, net income $78.6MQuarter to 31 Dec 2022: revenue $758.0M, net income $78.6MQuarter to 2 Apr 2023: revenue $710.9M, net income $76.7MQuarter to 2 Apr 2023: revenue $710.9M, net income $76.7MQuarter to 2 Jul 2023: revenue $743.3M, net income $111.3MQuarter to 2 Jul 2023: revenue $743.3M, net income $111.3MQuarter to 1 Oct 2023: revenue $746.4M, net income $137.1MQuarter to 1 Oct 2023: revenue $746.4M, net income $137.1MQuarter to 31 Dec 2023: revenue $773.9M, net income $31.1MQuarter to 31 Dec 2023: revenue $773.9M, net income $31.1MQuarter to 31 Mar 2024: revenue $737.8M, net income $15.3MQuarter to 31 Mar 2024: revenue $737.8M, net income $15.3MQuarter to 30 Jun 2024: revenue $749.7M, net income $80.0MQuarter to 30 Jun 2024: revenue $749.7M, net income $80.0MQuarter to 29 Sep 2024: revenue $764.4M, net income $111.0MQuarter to 29 Sep 2024: revenue $764.4M, net income $111.0MQuarter to 31 Dec 2024: revenue $442.0M, net income -$136.7MQuarter to 31 Dec 2024: revenue $442.0M, net income -$136.7MQuarter to 30 Mar 2025: revenue $700.7M, net income $95.0MQuarter to 30 Mar 2025: revenue $700.7M, net income $95.0MQuarter to 29 Jun 2025: revenue $780.9M, net income $122.6MQuarter to 29 Jun 2025: revenue $780.9M, net income $122.6MQuarter to 28 Sep 2025: revenue $913.0M, net income -$408.9MQuarter to 28 Sep 2025: revenue $913.0M, net income -$408.9MQuarter to 31 Dec 2025: revenue $569.0M, net income -$714.3MQuarter to 31 Dec 2025: revenue $569.0M, net income -$714.3MQuarter to 31 Mar 2026: revenue $548.3M, net income -$8.2MQuarter to 31 Mar 2026: revenue $548.3M, net income -$8.2MQuarter to 30 Jun 2026: revenue $570.3M, net income $99.7MQuarter to 30 Jun 2026: revenue $570.3M, net income $99.7MQuarter to 30 Sep 2026: revenue $567.8M, net income $927.4MQuarter to 30 Sep 2026: revenue $567.8M, net income $927.4M
31 Dec 2021RevenueNet incomeNet losstallest bar $927.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$567.8M$927.4M
30 Jun 2026$570.3M$99.7M
31 Mar 2026$548.3M-$8.2M
31 Dec 2025$569.0M-$714.3M
28 Sep 2025$913.0M-$408.9M
29 Jun 2025$780.9M$122.6M
30 Mar 2025$700.7M$95.0M
31 Dec 2024$442.0M-$136.7M
29 Sep 2024$764.4M$111.0M
30 Jun 2024$749.7M$80.0M
31 Mar 2024$737.8M$15.3M
31 Dec 2023$773.9M$31.1M
1 Oct 2023$746.4M$137.1M
2 Jul 2023$743.3M$111.3M
2 Apr 2023$710.9M$76.7M
31 Dec 2022$758.0M$78.6M
25 Sep 2022$686.8M$101.9M
26 Jun 2022$704.5M$105.5M
27 Mar 2022$641.7M$77.1M
31 Dec 2021$761.9M$128.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.3B $1.9B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +21% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $304.6M -$328.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $8.23 -$7.33
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 58.3% 58.0% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 9.4% 8.4% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 13.5% -17.6% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 8.3% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – $225.3M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $430.5M $354.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.6B $2.7B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $1.2B $2.3B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.46 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $88.09
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 21.0 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.8 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.4 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.8 2.8
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 0.84% 1.4%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
TeleflexTFX (this company) $6.4B21.02.8+21%13.5%
HaemoneticsHAE $5.5B52.74.0+4.1%7.5%
Merit Medical SystemsMMSI $5.1B31.63.1+9.1%9.9%
Globus MedicalGMED $8.9B16.12.9+13%17.8%
MiniMedMMED $4.5Bloss1.4–-9.6%
InsuletPODD $9.2B21.52.9+26%13.4%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.9%

385 13F filers vs 378

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

45.6M shares held by 13F filers (30 Sep 2026) of 39.7M outstanding (3 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

10%

4.1M shares sold short (30 Oct 2026) of 39.7M outstanding (3 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.9

4.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.6%

4.2M shares sold short in the report before, 4.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

79%

79% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

184

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-38%

$567.8M vs $913.0M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$481K

the 12 months before: $596K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$260K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

8

8 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

2.7×

8 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 4.8M, 5.2× a year earlier

Price $161.58 on 20 Nov 2026, +54% over 12 months (12-month range $100.34 to $165.85)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $634K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months, -83% on the 12 months before.
Revenue per quarter. Revenue $567.8M in the latest quarter, -38% on a year earlier.
Capital spending per quarter. Capital spending $18.8M in the latest quarter, -37% on a year earlier.
Institutional holders (13F filers). 385 13F filers reported holding it in the latest 13F quarter, -2.3% on a year earlier.
Federal obligations. Federal obligations: $668K published in the last 12 months, +66% on the 12 months before.
Lobbying spend. Lobbying spend: $260K published in the last 12 months, +18% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 4.1M vs usual 2.4M (2026-10-30); 2.2x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 4.2M vs usual 2.4M (2026-10-15); 2.3x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 4.1M vs usual 2.4M (2026-09-30); 2.2x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.3M (2026-09-15); 3.1x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.3M (2026-08-31); 4.3x the same period a year earlier
8 Sep 20268-K and other filingsDirector or officer change
8 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Sep 2026Sharp changeShort interest spike: short interest spike, 4.8M vs usual 2.2M (2026-08-14); 5.2x the same period a year earlier
3 Aug 20268-K and other filingsCompleted an acquisition or asset sale
9 Jun 20268-K and other filingsDirector or officer change
30 Apr 20268-K and other filingsDirector or officer change
30 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Feb 20268-K and other filingsRestructuring costs announced
23 Jan 20268-K and other filingsDirector or officer change
8 Jan 20268-K and other filingsDirector or officer change
8 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Dec 2025Sharp changeShort interest spike: short interest spike, 2.0M vs usual 1.1M (2025-11-28); 4.1x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 2.4M vs usual 1.1M (2025-11-14); 3.5x the same period a year earlier
8 Aug 2025Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 634K)
18 Jul 2025Sharp changeLobbying on a new issue: lobbying on a new issue: DEF, MED (2025-06-30)
29 Apr 2025Sharp changeShort interest spike: short interest spike, 1.6M vs usual 684K (2025-04-15); 2.2x the same period a year earlier
24 Apr 2025Lobbying filingnew lobbying registration (CORNERSTONE GOVERNMENT AFFAIRS, INC.)
15 Apr 2025Sharp changeShort interest spike: short interest spike, 2.5M vs usual 684K (2025-03-31); 2.8x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 2.4M vs usual 684K (2025-03-14); 3.0x the same period a year earlier
27 Feb 20258-K and other filingsDirector or officer change
27 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Aug 2024Sharp changeMany funds opening a new position: many funds opening a new position, 72 vs usual 47.50 (2024-06-30); 1.8x the same period a year earlier
9 May 20248-K and other filingsDirector or officer change
9 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 May 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 38.4M vs usual 21.0M (2024-03-31); 1.8x the same period a year earlier
11 Jan 2023Lobbying filingnew lobbying registration (ARNOLD & PORTER KAYE SCHOLER LLP)
21 Nov 20228-K and other filingsRestructuring costs announced
20 Oct 2022Sharp changeLobbying on a new issue: lobbying on a new issue: MMM (2022-09-30)
29 Sep 2022Lobbying filingnew lobbying registration (LIBERTY PARTNERS GROUP, LLC)
29 Sep 2022Sharp changeFirst lobbying registration: first lobbying registration: TELEFLEX (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA): new lobbying registration (LIBERTY PARTNERS GROUP, LLC)
16 Aug 2022Sharp changeShort interest spike: short interest spike, 1.6M vs usual 675K (2022-07-29); 2.4x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 1.5M vs usual 667K (2022-07-15); 2.4x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 1.1M vs usual 656K (2022-06-15); 2.6x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 1.2M vs usual 642K (2022-05-31); 2.9x the same period a year earlier
25 Feb 20228-K and other filingsDirector or officer change
25 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$2.7M published
Month from 1 Jun 2022: -$854K published
Month from 1 Jan 2023: -$4.1M published
Month from 1 May 2023: -$742K published
Month from 1 Dec 2023: -$9.7M published
Month from 1 Mar 2024: -$1.7M published
Month from 1 Aug 2024: -$639K published
Month from 1 Aug 2025: $634K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Jan 2024: 2 published
Quarter from 1 Oct 2024: 1 published
Quarter from 1 Jan 2025: 2 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 2 published
Quarter from 1 Oct 2025: 1 published
Quarter from 1 Jul 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $761.9M, +7.1% on a year earlier; public on 2 Mar 2022
Quarter ended 27 Mar 2022: $641.7M, +1.2% on a year earlier; public on 29 Apr 2022
Quarter ended 26 Jun 2022: $704.5M, -1.3% on a year earlier; public on 29 Jul 2022
Quarter ended 25 Sep 2022: $686.8M, -1.9% on a year earlier; public on 28 Oct 2022
Quarter ended 31 Dec 2022: $758.0M, -0.5% on a year earlier; public on 24 Feb 2023
Quarter ended 2 Apr 2023: $710.9M, +11% on a year earlier; public on 5 May 2023
Quarter ended 2 Jul 2023: $743.3M, +5.5% on a year earlier; public on 4 Aug 2023
Quarter ended 1 Oct 2023: $746.4M, +8.7% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $773.9M, +2.1% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $737.8M, +3.8% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $749.7M, +0.9% on a year earlier; public on 3 Aug 2024
Quarter ended 29 Sep 2024: $764.4M, +2.4% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $442.0M, -43% on a year earlier; public on 28 Feb 2026
Quarter ended 30 Mar 2025: $700.7M, -5.0% on a year earlier; public on 2 May 2025
Quarter ended 29 Jun 2025: $780.9M, +4.2% on a year earlier; public on 1 Aug 2025
Quarter ended 28 Sep 2025: $913.0M, +19% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $569.0M, +29% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $548.3M, -22% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $570.3M, -27% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $567.8M, -38% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $19.5M, -31% on a year earlier; public on 2 Mar 2022
Quarter ended 27 Mar 2022: $13.1M, -32% on a year earlier; public on 29 Apr 2022
Quarter ended 26 Jun 2022: $19.4M, +11% on a year earlier; public on 29 Jul 2022
Quarter ended 25 Sep 2022: $20.2M, +31% on a year earlier; public on 28 Oct 2022
Quarter ended 31 Dec 2022: $26.5M, +36% on a year earlier; public on 24 Feb 2023
Quarter ended 2 Apr 2023: $21.8M, +67% on a year earlier; public on 5 May 2023
Quarter ended 2 Jul 2023: $17.5M, -9.4% on a year earlier; public on 4 Aug 2023
Quarter ended 1 Oct 2023: $24.4M, +21% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $27.7M, +4.3% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $38.4M, +76% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $34.8M, +98% on a year earlier; public on 3 Aug 2024
Quarter ended 29 Sep 2024: $21.2M, -13% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $32.0M, +16% on a year earlier; public on 1 Mar 2025
Quarter ended 30 Mar 2025: $30.0M, -22% on a year earlier; public on 2 May 2025
Quarter ended 29 Jun 2025: $34.6M, -0.5% on a year earlier; public on 1 Aug 2025
Quarter ended 28 Sep 2025: $29.9M, +41% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $18.8M, -37% on a year earlier; public on 8 May 2026
Institutional holders (13F filers)
31 Dec 2021 report: 482; public on 14 Feb 2022
31 Mar 2022 report: 509; public on 16 May 2022
30 Jun 2022 report: 479; public on 15 Aug 2022
30 Sep 2022 report: 424; public on 14 Nov 2022
31 Dec 2022 report: 441; public on 14 Feb 2023
31 Mar 2023 report: 451; public on 15 May 2023
30 Jun 2023 report: 444; public on 14 Aug 2023
30 Sep 2023 report: 442; public on 14 Nov 2023
31 Dec 2023 report: 441; public on 14 Feb 2024
31 Mar 2024 report: 459; public on 15 May 2024
30 Jun 2024 report: 498; public on 14 Aug 2024
30 Sep 2024 report: 498; public on 14 Nov 2024
31 Dec 2024 report: 497; public on 14 Feb 2025
31 Mar 2025 report: 408; public on 15 May 2025
30 Jun 2025 report: 384; public on 14 Aug 2025
30 Sep 2025 report: 394; public on 14 Nov 2025
31 Dec 2025 report: 394; public on 17 Feb 2026
31 Mar 2026 report: 353; public on 15 May 2026
30 Jun 2026 report: 378; public on 14 Aug 2026
30 Sep 2026 report: 385; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $807 published
Month from 1 Dec 2021: $286K published
Month from 1 Jan 2022: $61K published
Month from 1 Feb 2022: $20K published
Month from 1 Mar 2022: $1K published
Month from 1 Apr 2022: $984K published
Month from 1 May 2022: $57K published
Month from 1 Jun 2022: $97K published
Month from 1 Jul 2022: $1.1M published
Month from 1 Aug 2022: $31K published
Month from 1 Sep 2022: $67K published
Month from 1 Oct 2022: $34K published
Month from 1 Nov 2022: $77K published
Month from 1 Dec 2022: $45K published
Month from 1 Jan 2023: $42K published
Month from 1 Feb 2023: $0 published
Month from 1 Mar 2023: $28K published
Month from 1 Apr 2023: $41K published
Month from 1 May 2023: -$2K published
Month from 1 Jun 2023: $101K published
Month from 1 Jul 2023: $67K published
Month from 1 Aug 2023: $1.0M published
Month from 1 Sep 2023: $86K published
Month from 1 Oct 2023: $5K published
Month from 1 Nov 2023: $4.5M published
Month from 1 Dec 2023: $65K published
Month from 1 Jan 2024: $43K published
Month from 1 Feb 2024: $29K published
Month from 1 Mar 2024: $43K published
Month from 1 Apr 2024: $2K published
Month from 1 May 2024: $36K published
Month from 1 Jun 2024: $67K published
Month from 1 Jul 2024: $70K published
Month from 1 Aug 2024: $141K published
Month from 1 Sep 2024: $90K published
Month from 1 Oct 2024: $48K published
Month from 1 Nov 2024: $5K published
Month from 1 Dec 2024: $7K published
Month from 1 Jan 2025: $8K published
Month from 1 Feb 2025: -$74K published
Month from 1 Mar 2025: $6K published
Month from 1 Apr 2025: $48K published
Month from 1 May 2025: $111K published
Month from 1 Jun 2025: $43K published
Month from 1 Jul 2025: $40K published
Month from 1 Aug 2025: $28K published
Month from 1 Sep 2025: $151K published
Month from 1 Oct 2025: $17K published
Month from 1 Nov 2025: $19K published
Month from 1 Dec 2025: $79 published
Month from 1 Jan 2026: $13K published
Month from 1 Feb 2026: $1K published
Month from 1 Mar 2026: $19K published
Month from 1 Apr 2026: $4K published
Month from 1 May 2026: -$5K published
Month from 1 Jun 2026: $103K published
Month from 1 Jul 2026: $24K published
Month from 1 Aug 2026: $12K published
Month from 1 Sep 2026: $255K published
Month from 1 Oct 2026: $241K published
Lobbying spend
Quarter from 1 Jan 2023: $30K published
Quarter from 1 Apr 2023: $30K published
Quarter from 1 Jul 2023: $30K published
Quarter from 1 Oct 2023: $30K published
Quarter from 1 Jan 2024: $30K published
Quarter from 1 Apr 2024: $30K published
Quarter from 1 Jul 2024: $30K published
Quarter from 1 Oct 2024: $30K published
Quarter from 1 Jan 2025: $30K published
Quarter from 1 Apr 2025: $30K published
Quarter from 1 Jul 2025: $90K published
Quarter from 1 Oct 2025: $70K published
Quarter from 1 Jan 2026: $60K published
Quarter from 1 Apr 2026: $70K published
Quarter from 1 Jul 2026: $60K published
Quarter from 1 Oct 2026: $70K published

What is unusual now

  • Made public in the last 90 days: it had 4.8M shares sold short in the 14 Aug 2026 report, 5.2× the same report last year; it also had 4.2M shares sold short in the 15 Oct 2026 report, 2.3× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 4.8M shares sold short in the 14 Aug 2026 report, 5.2× the same report last year Public on 26 Aug 2026.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $634K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months, -83% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 7 Aug 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
7 Aug 2025Jaewon RyuDirectorBuy1,500$115.00$172KForm 4
7 Aug 2025Gretchen R HaggertyDirectorBuy500$114.75$57KForm 4
7 Aug 2025Liam KellyChairman, President & CEOBuy1,500$115.07$173KForm 4
7 Aug 2025Andrew A KrakauerDirectorBuy1,000$115.25$115KForm 4
7 Aug 2025Stuart A RandleDirectorBuy1,000$115.86$116KForm 4
16 Aug 2024Stuart A RandleDirectorSellafter exercising options2,674$238.93$639KForm 4
5 Mar 2024Cameron P HicksCorp. VP & Chief HR OfficerSellafter exercising options7,401$225.00$1.7MForm 4
29 Dec 2023Liam KellyChairman, President & CEOSellplanned in advance (10b5-1); after exercising options26,256$250.23$6.6MForm 4

385 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 55 opened a position, 43 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.5.2M13.1%$651.8M-219K-4.0%
Janus Henderson Group Ltd.4.3M11.0%$543.8M
T. Rowe Price Investment Management, Inc.2.6M6.50%-615K-19%
Vanguard Portfolio Management LLC2.3M5.86%$290.7M-92K-3.8%
Vanguard Capital Management LLC1.9M4.80%$238.2M-91K-4.6%
Sessa Capital IM, L.P.1.5M3.85%$190.8MNo change
State Street Corp1.4M3.64%$180.4M-41K-2.8%
Fuller & Thaler Asset Management, Inc.1.2M3.03%$150.5M-118K-8.9%
Dimensional Fund Advisors LP1.2M2.97%$147.4M+26K+2.3%
Invesco Ltd.1.1M2.80%$138.7M+535K+93%

Federal contracts

All 3 federal contracts

No new award in 12 months; the latest was signed 9 Sep 2020. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
9 Sep 2020Department of DefenseDepartment of the Army$1.6Mup to $3.3MFREEZE DRIED PLASMA COMMERCIAL VIABILITY ACTIVITIESUSAspending
3 Sep 2014Department of Defense$3.8MANTI-BIOFILM TRAUMA DEVICES - PHASE TWOGrantUSAspending
19 Jul 2011Department of DefenseDepartment of the Army$1.0MANTI-BIOFILM TRAUMA DEVICESGrantUSAspending

Company events

All 40 company events

In 12 months: 5 director or officer changes, 3 major agreements, 1 restructuring, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
8 Sep 2026Director or officer change8-K
3 Aug 2026Completed an acquisition or asset sale8-K
15 Jun 2026Signed a major agreementSame filing: took on new debt8-K
9 Jun 2026Director or officer change8-K
27 May 2026Signed a major agreementSame filing: took on new debt8-K
30 Apr 2026Director or officer change8-K
26 Feb 2026Restructuring costs announced8-K
23 Jan 2026Director or officer change8-K

184 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 25%, Manufacturing & production 11%, Test, quality & reliability 10%, Supply chain & procurement 8%.

PostedJobLocation
21 Nov 2026or earlierSales Representative/ Senior Representative, OnControl-Interventional Oncology, WI-MNSales & business developmentMilwaukee, WI, US
21 Nov 2026or earlierSales Rep, OnControl, Seattle WASales & business developmentSeattle, WA, US
21 Nov 2026or earlierGebäudeinformatiker EFZBülach, ZH, CH
21 Nov 2026or earlierMetrologistWyomissing, PA, US
21 Nov 2026or earlierSpécialiste Clinique des ventes (CSS) - Ventes vasculairesMarketing & communicationsQuebec, QC, CA
21 Nov 2026or earlierSupply Chain Manager - Logistics & Distribution EMEA UKSupply chain & procurementAthlone, L, IE
21 Nov 2026or earlierProduct Manager Interventional LATAMProduct managementMexico City or Bogota, Colombi, CMX, MX
21 Nov 2026or earlierQuality Engineer IITest, quality & reliabilityOlive Branch, MS, US

Reported lobbying spend: $70K in Q3 2026, $60K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2025NewCornerstone Government Affairs, Inc.for Teleflex IncorporatedEducating Department of Defense officials on Teleflexs combat casualty care and emergency medicine capabilities to support the military health system.Defense, MEDFiling
1 Nov 2022NewArnold & Porter Kaye Scholer LLPfor Teleflex IncorporatedMedicare coverage and reimbursement issues.Health issues, Medicare/MedicaidFiling
23 Sep 2022NewLiberty Partners Group, LLCfor Teleflex (Office-Based Facility Assn Obfa) (Fka Uspa)Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform.Medicare/MedicaidFiling
31 Dec 2010EndedCrowell & Moring LLPfor Teleflex, Inc.Not statedFiling
1 Jan 2009NewCrowell & Moring LLPfor Teleflex, Inc.Extension of duty exemptions.TradeFiling
31 Dec 2008EndedC&M Capitolinkfor Teleflex IncExtention of duty exemptions.TradeFiling
28 Jan 2008NewC&M Capitolinkfor Teleflex IncExtention of duty exemptionsTradeFiling
5 Aug 2002NewTroutman Pepper Locke, LLPfor Teleflex IncAER, Transportation, AviationFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Nov 2012. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Nov 2012TeleflexLumberton, NJ1531 Feb 2013Notice

The 5 newest of 163 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

8 Aug 2025confirmed

Confirmed across sources Insiders and Lobbying

Teleflex (TFX): lobbying on a new issue, while it had 5 insiders buy $634K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 20 days.

  • Lobbying: Lobbying on a new issue, became public on 18 Jul 2025
  • Insiders: Clustered insider buying, became public on 8 Aug 2025
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 18 Jul 2025

Teleflex lobbying on a new issue.

New
['DEF', 'MED']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4846415

Insiders: Clustered insider buying became public on 8 Aug 2025

Teleflex had 5 insiders buy $634K of its shares on the open market within 30 days (5 filings).

Independent buyers
5
Purchase filings (Form 4, code P)
5
Total bought
$634K
Window
9 Jul 2025 to 8 Aug 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 4.1M shares sold short in the 30 Oct 2026 report, 2.2× the same report last year.

    Same report last year: 1.8M; its normal report is 2.4M.

    See the evidence
    This period
    4.1M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    309K
    How far from its usual level
    +3.6
    Same report last year
    1.8M
    History used
    3,227 days
    2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M2026-08-31: 4.0M2026-09-15: 4.0M2026-09-30: 4.1M2026-10-15: 4.2M2026-10-30: 4.1M
    the 30 Oct 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 27 Oct 2026Short interest and volume change

    had 4.2M shares sold short in the 15 Oct 2026 report, 2.3× the same report last year.

    Same report last year: 1.9M; its normal report is 2.4M.

    See the evidence
    This period
    4.2M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +4.2
    Same report last year
    1.9M
    History used
    3,212 days
    2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M2026-08-31: 4.0M2026-09-15: 4.0M2026-09-30: 4.1M2026-10-15: 4.2M
    the 15 Oct 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2026Short interest and volume change

    had 4.1M shares sold short in the 30 Sep 2026 report, 2.2× the same report last year.

    Same report last year: 1.8M; its normal report is 2.4M.

    See the evidence
    This period
    4.1M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +3.9
    Same report last year
    1.8M
    History used
    3,197 days
    2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M2026-08-31: 4.0M2026-09-15: 4.0M2026-09-30: 4.1M
    the 30 Sep 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2026Short interest and volume change

    had 4.0M shares sold short in the 15 Sep 2026 report, 3.1× the same report last year.

    Same report last year: 1.3M; its normal report is 2.3M.

    See the evidence
    This period
    4.0M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +3.9
    Same report last year
    1.3M
    History used
    3,182 days
    2025-09-15: 1.3M2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M2026-08-31: 4.0M2026-09-15: 4.0M
    the 15 Sep 2026 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Sep 2026Short interest and volume change

    had 4.0M shares sold short in the 31 Aug 2026 report, 4.3× the same report last year.

    Same report last year: 943K; its normal report is 2.3M.

    See the evidence
    This period
    4.0M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +4.0
    Same report last year
    943K
    History used
    3,167 days
    2025-08-29: 943K2025-09-15: 1.3M2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M2026-08-31: 4.0M
    the 31 Aug 2026 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 8 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 8 Sep 2026Filings record

    Director or officer change

  8. 26 Aug 2026Short interest and volume change

    had 4.8M shares sold short in the 14 Aug 2026 report, 5.2× the same report last year.

    Same report last year: 936K; its normal report is 2.2M.

    See the evidence
    This period
    4.8M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    283K
    How far from its usual level
    +6.2
    Same report last year
    936K
    History used
    3,150 days
    2025-08-15: 936K2025-08-29: 943K2025-09-15: 1.3M2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M2025-12-15: 1.7M2025-12-31: 1.7M2026-01-15: 1.9M2026-01-30: 2.2M2026-02-13: 2.4M2026-02-27: 2.5M2026-03-13: 2.3M2026-03-31: 2.6M2026-04-15: 2.4M2026-04-30: 2.2M2026-05-15: 2.4M2026-05-29: 2.4M2026-06-15: 2.3M2026-06-30: 2.5M2026-07-15: 2.8M2026-07-31: 3.0M2026-08-14: 4.8M
    the 14 Aug 2026 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 3 Aug 2026Filings record

    Completed an acquisition or asset sale

  10. 9 Jun 2026Filings record

    Director or officer change

  11. 30 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 30 Apr 2026Filings record

    Director or officer change

  13. 26 Feb 2026Filings record

    Restructuring costs announced

  14. 23 Jan 2026Filings record

    Director or officer change

  15. 8 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 8 Jan 2026Filings record

    Director or officer change

  17. 10 Dec 2025Short interest and volume change

    had 2.0M shares sold short in the 28 Nov 2025 report, 4.1× the same report last year.

    Same report last year: 494K; its normal report is 1.1M.

    See the evidence
    This period
    2.0M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    179K
    How far from its usual level
    +3.5
    Same report last year
    494K
    History used
    2,891 days
    2024-11-29: 494K2024-12-13: 554K2024-12-31: 802K2025-01-15: 1.1M2025-01-31: 1.1M2025-02-14: 1.2M2025-02-28: 1.1M2025-03-14: 2.4M2025-03-31: 2.5M2025-04-15: 1.6M2025-04-30: 1.1M2025-05-15: 1.1M2025-05-30: 1.0M2025-06-13: 1.0M2025-06-30: 993K2025-07-15: 1.1M2025-07-31: 883K2025-08-15: 936K2025-08-29: 943K2025-09-15: 1.3M2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M2025-11-28: 2.0M
    the 28 Nov 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 26 Nov 2025Short interest and volume change

    had 2.4M shares sold short in the 14 Nov 2025 report, 3.5× the same report last year.

    Same report last year: 675K; its normal report is 1.1M.

    See the evidence
    This period
    2.4M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    173K
    How far from its usual level
    +5.0
    Same report last year
    675K
    History used
    2,877 days
    2024-11-15: 675K2024-11-29: 494K2024-12-13: 554K2024-12-31: 802K2025-01-15: 1.1M2025-01-31: 1.1M2025-02-14: 1.2M2025-02-28: 1.1M2025-03-14: 2.4M2025-03-31: 2.5M2025-04-15: 1.6M2025-04-30: 1.1M2025-05-15: 1.1M2025-05-30: 1.0M2025-06-13: 1.0M2025-06-30: 993K2025-07-15: 1.1M2025-07-31: 883K2025-08-15: 936K2025-08-29: 943K2025-09-15: 1.3M2025-09-30: 1.8M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 2.4M
    the 14 Nov 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 8 Aug 2025several at once

    lobbying on a new issue, while it had 5 insiders buy $634K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 20 days.

    See the evidence (2 changes)

    Lobbying: Lobbying on a new issue became public on 18 Jul 2025

    Teleflex lobbying on a new issue.

    New
    ['DEF', 'MED']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4846415

    Insiders: Clustered insider buying became public on 8 Aug 2025

    Teleflex had 5 insiders buy $634K of its shares on the open market within 30 days (5 filings).

    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $634K
    Window
    9 Jul 2025 to 8 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  20. 8 Aug 2025Insiders change

    had 5 insiders buy $634K of its shares on the open market within 30 days (5 filings).

    Who bought: Randle Stuart A, Krakauer Andrew A, Kelly Liam, Haggerty Gretchen R and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $634K
    Window
    9 Jul 2025 to 8 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  21. 8 Aug 2025Insiders record

    Ryu Jaewon (director) bought 1,500 shares of TFX ($172,500) (dated 7 Aug 2025)

  22. 8 Aug 2025Insiders record

    HAGGERTY GRETCHEN R (director) bought 500 shares of TFX ($57,375) (dated 7 Aug 2025)

  23. 8 Aug 2025Insiders record

    Kelly Liam (Chairman, President & CEO) bought 1,500 shares of TFX ($172,605) (dated 7 Aug 2025)

  24. 8 Aug 2025Insiders record

    Krakauer Andrew A (director) bought 1,000 shares of TFX ($115,250) (dated 7 Aug 2025)

  25. 8 Aug 2025Insiders record

    RANDLE STUART A (director) bought 1,000 shares of TFX ($115,860) (dated 7 Aug 2025)

  26. 18 Jul 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['DEF', 'MED']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4846415
  27. 26 Apr 2025Short interest and volume change

    had 1.6M shares sold short in the 15 Apr 2025 report, 2.2× the same report last year.

    Same report last year: 712K; its normal report is 684K.

    See the evidence
    This period
    1.6M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    684K
    Typical spread (median absolute deviation)
    125K
    How far from its usual level
    +4.7
    Same report last year
    712K
    History used
    2,664 days
    2024-04-15: 712K2024-04-30: 590K2024-05-15: 865K2024-05-31: 843K2024-06-14: 679K2024-06-28: 620K2024-07-15: 644K2024-07-31: 361K2024-08-15: 564K2024-08-30: 473K2024-09-13: 569K2024-09-30: 755K2024-10-15: 689K2024-10-31: 658K2024-11-15: 675K2024-11-29: 494K2024-12-13: 554K2024-12-31: 802K2025-01-15: 1.1M2025-01-31: 1.1M2025-02-14: 1.2M2025-02-28: 1.1M2025-03-14: 2.4M2025-03-31: 2.5M2025-04-15: 1.6M
    the 15 Apr 2025 report24 earlier reportsnormal: 684K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 24 Apr 2025Lobbying record

    TELEFLEX INCORPORATED: new lobbying registration (CORNERSTONE GOVERNMENT AFFAIRS, INC.) (dated 1 Apr 2025)

  29. 10 Apr 2025Short interest and volume change

    had 2.5M shares sold short in the 31 Mar 2025 report, 2.8× the same report last year.

    Same report last year: 888K; its normal report is 684K.

    See the evidence
    This period
    2.5M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    684K
    Typical spread (median absolute deviation)
    125K
    How far from its usual level
    +9.7
    Same report last year
    888K
    History used
    2,649 days
    2024-03-28: 888K2024-04-15: 712K2024-04-30: 590K2024-05-15: 865K2024-05-31: 843K2024-06-14: 679K2024-06-28: 620K2024-07-15: 644K2024-07-31: 361K2024-08-15: 564K2024-08-30: 473K2024-09-13: 569K2024-09-30: 755K2024-10-15: 689K2024-10-31: 658K2024-11-15: 675K2024-11-29: 494K2024-12-13: 554K2024-12-31: 802K2025-01-15: 1.1M2025-01-31: 1.1M2025-02-14: 1.2M2025-02-28: 1.1M2025-03-14: 2.4M2025-03-31: 2.5M
    the 31 Mar 2025 report24 earlier reportsnormal: 684K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 26 Mar 2025Short interest and volume change

    had 2.4M shares sold short in the 14 Mar 2025 report, 3.0× the same report last year.

    Same report last year: 817K; its normal report is 684K.

    See the evidence
    This period
    2.4M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    684K
    Typical spread (median absolute deviation)
    125K
    How far from its usual level
    +9.4
    Same report last year
    817K
    History used
    2,632 days
    2024-03-15: 817K2024-03-28: 888K2024-04-15: 712K2024-04-30: 590K2024-05-15: 865K2024-05-31: 843K2024-06-14: 679K2024-06-28: 620K2024-07-15: 644K2024-07-31: 361K2024-08-15: 564K2024-08-30: 473K2024-09-13: 569K2024-09-30: 755K2024-10-15: 689K2024-10-31: 658K2024-11-15: 675K2024-11-29: 494K2024-12-13: 554K2024-12-31: 802K2025-01-15: 1.1M2025-01-31: 1.1M2025-02-14: 1.2M2025-02-28: 1.1M2025-03-14: 2.4M
    the 14 Mar 2025 report24 earlier reportsnormal: 684K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 27 Feb 2025Filings record

    Director or officer change

  33. 14 Aug 2024Institutional holdings change

    saw 72 13F filers open a new position in the quarter ended 30 Jun 2024, 1.8× the same quarter last year.

    Same quarter last year: 40; its normal quarter is 47.5.

    See the evidence
    This period
    72 (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    47.5
    Typical spread (median absolute deviation)
    4.5
    How far from its usual level
    +3.7
    Same quarter last year
    40
    History used
    3,926 days
    2022-06-30: 542022-09-30: 292022-12-31: 662023-03-31: 482023-06-30: 402023-09-30: 452023-12-31: 482024-03-31: 472024-06-30: 72
    the quarter ended 30 Jun 20248 earlier quartersnormal: 47.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  34. 9 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 9 May 2024Filings record

    Director or officer change

  36. 7 May 2024Financials change

    spent $38.4M on capital projects in the quarter ended 31 Mar 2024, 1.8× the same quarter last year.

    Same quarter last year: $21.8M; its normal quarter is $21.0M.

    See the evidence
    This period
    $38.4M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $21.0M
    Typical spread (median absolute deviation)
    $3.4M
    How far from its usual level
    +3.4
    Same quarter last year
    $21.8M
    History used
    5,299 days
    2022-03-27: $13.1M2022-06-26: $19.4M2022-09-25: $20.2M2022-12-31: $26.5M2023-04-02: $21.8M2023-07-02: $17.5M2023-10-01: $24.4M2023-12-31: $27.7M2024-03-31: $38.4M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $21.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  37. 11 Jan 2023Lobbying record

    TELEFLEX INCORPORATED: new lobbying registration (ARNOLD & PORTER KAYE SCHOLER LLP) (dated 1 Nov 2022)

  38. 21 Nov 2022Filings record

    Restructuring costs announced

  39. 20 Oct 2022Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MMM']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12727079
  40. 29 Sep 2022Lobbying change

    registered for federal lobbying for the first time in our data (Liberty Partners Group, Llc).

    See the evidence (1 source record)
    Source coverage starts
    6 Oct 2009
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Showing the newest 40 of 77 entries; narrow the window or the kind of data to see older ones.

Not listed: 261 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000096943
Ticker
TFX
Domain
teleflex.com
Employer name
Teleflex LLC (1 unverified)
Hq location
PA|WAYNE|19087 (1 unverified)
Lobbying client
teleflex, teleflex office based facility assn obfa fka uspa
Name
as of December 31, 2025, Teleflex Incorporated
Uei
F2K7LCEKZBK1, SYB1TESAMZ43, US6UJ1MT1MM5, WHUHCZMHGKK3
Wikidata
Q7696143
Wikipedia
Teleflex
  • DOL H-1B labor condition applications and PERM certifications118 data points20 Jul 2020 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)8 records, 94 data points5 Aug 2002 to 30 Sep 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)162 records25 Feb 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1230 data points31 Dec 2007 to 3 Nov 2026
  • SEC Form 4 insider transactions135 records, 468 data points18 May 2016 to 7 Aug 2025
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards3 records, 7410 data points1 Oct 2007 to 14 Oct 2026
  • WARN layoff notices (state labor agencies)1 record, 3 data points29 Oct 2012 to 1 Nov 2012
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026